📖 Approx. 3 min
In this article, a medical industry-specialized M&A advisor explains from a practical perspective what issues member succession entails in business succession and medical M&A involving business valuation. We will provide specific countermeasures based on DCF, net asset, and comparable company analysis methods, and the succession of non-equity medical corporations.
1. Industry Background of Member Succession and Business Valuation
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including business valuation, has become increasingly severe in recent years due to complex factors such as revisions to medical fees, rising personnel costs, and the burden of capital investment. Particularly from the perspective of DCF, net asset, and comparable company analysis methods, interest in third-party succession M&A is growing.
At the same time, member succession is a crucial issue in medical M&A practice. By properly designing the succession of non-equity medical corporations, a succession beneficial to both the transferor and transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the business flow, patient base, and equipment status specific to business valuation, and clarify the transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the characteristics of the medical department. DCF, net asset, and comparable company analysis methods are key to business valuation.
- Designing Member Succession: Select the optimal scheme based on the succession of non-equity medical corporations. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select potential transferees suitable for the medical department’s characteristics from a nationwide network. Carefully align desired conditions.
- Due Diligence: Thorough investigation from financial, legal, labor, and medical practice perspectives. Also confirm licenses, permits, and facility standards specific to business valuation.
- Final Agreement & Closing: Conclude the final agreement, including representations and warranties, and indemnity clauses. Proceed with license/permit transfer and staff notification in parallel.
3. Specific Considerations in Business Valuation
In medical institution M&A involving business valuation, DCF, net asset, and comparable company analysis methods hold the key to successful succession. There are numerous individual issues depending on the characteristics of the medical department, such as the continuity of the patient base, maintaining employment for staff (doctors, nurses, allied health professionals), equipment status and renewal plans, and maintaining/acquiring facility standards.
Furthermore, strategic design based on market characteristics unique to business valuation, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with neighboring competing medical institutions, is crucial. Leveraging our track record in supporting business valuation succession, we provide practical support from an industry-specific perspective.
4. Practical Details of Member Succession
Member succession is an area that requires specialized consideration in medical M&A. Designing it based on the succession of non-equity medical corporations is key to success.
- Confirmation of Relevant Laws & Practical Standards: Preparation based on the Medical Care Act, tax laws, and labor laws.
- Collaboration with Professionals: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Between Parties: Designing conditions satisfactory to both the transferor and transferee.
- Proper Documentation: Clear specification in the basic agreement and final contract.
Frequently Asked Questions
Q. What documents are required for a consultation?
A. It would be helpful if you could prepare financial statements for the last three fiscal years, patient number trends, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after an NDA is signed.
Q. What is the market price range for business valuation transfers?
A. Business valuation is based on DCF, net asset, and comparable company analysis methods. For clinics without beds, it’s typically 0.5 to 1.5 times annual revenue, and for hospitals with beds, EBITDA multiples of 3 to 7 times are a guideline. We will provide details in a free preliminary assessment.
Q. What are the points to note when proceeding with member succession?
A. Prior planning based on the succession of non-equity medical corporations is essential. Seamless execution of practical matters through collaboration with professionals is key to success.
Q. Will staff or patients find out about the consultation?
A. Information disclosure is limited after an NDA is signed, and no disclosure to stakeholders will occur before the final agreement. We ensure strict confidentiality.
Related Columns
- Complete Guide to Hospital and Medical Corporation Business Succession M&A
- The Full Picture of Clinic Sale/Transfer: Market Price, Process, and Considerations
- How to Proceed with Medical M&A and Hospital Succession | Duration, Costs, and Considerations
- Tax Schemes for Medical Corporation M&A: Key Issues for Professionals
For consultations on Member Succession and Business Valuation, contact M&A Medical.
Strict Confidentiality – Free Initial Consultation – Success Fee Basis